InsidersTradesSigma
Follow the HK이노엔 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, HK이노엔 has logged 3 reports. Market capitalisation: €1,029.8bn. The latest transaction was filed on 22 April 2026 (Purchase). Among the most active insiders: 한국콜마. The full history is free.
Analysts rate HK이노엔 Buy (bullish), based on 12 analysts. Average price target: ₩65,500.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
HK이노엔 is a healthcare and pharmaceutical company listed on the XKRX. It specializes in the development and commercialization of innovative pharmaceutical products.